Human determinants and the role of melanocortin-1 receptor variants in melanoma risk independent of UV Radiation Exposure

JAMA Dermatology

Volumn 152, Issue 7, 2016, Pages 776-782

  Wendt, Judith ^a   Rauscher, Sabine ^a   Burgstaller Muehlbacher, Sebastian ^a,b   Fae, Ingrid ^c   Fischer, Gottfried ^c   Pehamberger, Hubert ^a   Okamoto, Ichiro ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MELANOCORTIN 1 RECEPTOR;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER PATIENT; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOME SIZE; HETEROZYGOTE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION EXPOSURE; RISK FACTOR; SEQUENCE ANALYSIS; SKIN DEFECT; SUN EXPOSURE; SUNBURN; ULTRAVIOLET RADIATION; ADVERSE EFFECTS; AGED; BACK; CASE CONTROL STUDY; FACE; GENETIC SCREENING; GENETIC VARIATION; GENETICS; HAND; KERATOSIS, ACTINIC; MIDDLE AGED; QUESTIONNAIRE; SKIN TUMOR;

ADULT; AGED; BACK; CASE-CONTROL STUDIES; FACE; FEMALE; GENETIC TESTING; GENETIC VARIATION; HAND; HUMANS; KERATOSIS, ACTINIC; MALE; MELANOMA; MIDDLE AGED; RECEPTOR, MELANOCORTIN, TYPE 1; RISK FACTORS; SKIN NEOPLASMS; SUNBURN; SURVEYS AND QUESTIONNAIRES; ULTRAVIOLET RAYS;

EID: 84968873700     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2016.0050     Document Type: Article

References (38)

1. Valverde P, Healy E, Sikkink S, et al. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet. 1996;5(10):1663-1666.
2. Cho E, Rosner BA, Feskanich D, Colditz GA. Risk factors and individual probabilities of melanoma for whites. J Clin Oncol. 2005;23(12):2669-2675.
3. Bataille V. Genetic epidemiology of melanoma. Eur J Cancer. 2003;39(10):1341-1347.
4. Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene. 2003;22(20):3099-3112.
5. Thomson CS, Woolnough S, Wickenden M, Hiom S, Twelves CJ. Sunbed use in children aged 11-17 in England: face to face quota sampling surveys in the National Prevalence Study and Six Cities Study. BMJ. 2010;340:c877.
6. Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. Nature. 2007;445(7130):843-850.
7. Wong TH, Rees JL. The relation between melanocortin 1 receptor (MC1R) variation and the generation of phenotypic diversity in the cutaneous response to ultraviolet radiation. Peptides. 2005; 26(10):1965-1971.
8. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet. 1995;11(3):328-330.
9. Box NF, Wyeth JR, OGorman LE, Martin NG, Sturm RA. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair.HumMol Genet. 1997;6(11):1891-1897.
10. Mitra D, Luo X, Morgan A, et al. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature. 2012;491(7424):449-453.
11. Wendt J, Rauscher S, Burgstaller-Möhlbacher S, et al. Actinic damage on the back is significantly determined by MC1R variants and previous sun exposure compared with other body sites in amultivariate analysis. Br J Dermatol. 2014;171(3):622-630.
12. Marrett LD, King WD, Walter SD, From L. Use of host factors to identify people at high risk for cutaneous malignant melanoma. CMAJ. 1992;147 (4):445-453.
13. Ortonne JP. Pigmentary changes of the ageing skin. Br J Dermatol. 1990;122(suppl 35):21-28.
14. Schäfer T, Merkl J, Klemm E, Wichmann HE, Ring J; KORA Study Group. The epidemiology of nevi and signs of skin aging in the adult general population: results of the KORA-survey 2000. J Invest Dermatol. 2006;126(7):1490-1496.
15. Wendt J, Schanab O, Binder M, Pehamberger H, Okamoto I. Site-dependent actinic skin damage as risk factor for melanoma in a central European population. Pigment Cell Melanoma Res. 2012;25 (2):234-242.
16. Landi MT, Bauer J, Pfeiffer RM, et al. MC1R germline variants confer risk for BRAF-mutant melanoma. Science. 2006;313(5786):521-522.
17. Smith R, Healy E, Siddiqui S, et al. Melanocortin 1 receptor variants in an Irish population. J Invest Dermatol. 1998;111(1):119-122.
18. Kanetsky PA, Rebbeck TR, Hummer AJ, et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res. 2006;66(18):9330-9337.
19. Kanetsky PA, Panossian S, Elder DE, et al. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? Cancer. 2010;116(10):2416-2428.
20. Palmer JS, Duffy DL, Box NF, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet. 2000; 66(1):176-186.
21. Beaumont KA, Shekar SN, Cook AL, Duffy DL, Sturm RA. Red hair is the null phenotype of MC1R. Hum Mutat. 2008;29(8):E88-E94.
22. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 2003;95(11):806-812.
23. Scherer D, Nagore E, Bermejo JL, et al. Melanocortin receptor 1 variants and melanoma risk: A study of 2 European populations. Int J Cancer. 2009;125(8):1868-1875.
24. Galore-Haskel G, Azizi E, Mohamdi H, et al. MC1R variant alleles and malignant melanoma risk in Israel. Eur J Cancer. 2009;45(11):2015-2022.
25. Hacker E, Nagore E, Cerroni L, et al. NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations. J Invest Dermatol. 2013;133(4):1027-1033.
26. Sturm RA, Duffy DL, Box NF, et al. The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. Pigment Cell Res. 2003;16 (3):266-272.
27. Raimondi S, Sera F, Gandini S, et al. MC1R variants, melanoma and red hair color phenotype: Ameta-Analysis. Int J Cancer. 2008;122(12):2753-2760.
28. Fargnoli MC, Argenziano G, Zalaudek I, Peris K. High-And low-penetrance cutaneous melanoma susceptibility genes. Expert Rev Anticancer Ther. 2006;6(5):657-670.
29. Han J, Colditz GA, Hunter DJ. Risk factors for skin cancers: A nested case-control study within the Nurses Health Study. Int J Epidemiol. 2006;35(6): 1514-1521.
30. Kennedy C, ter Huurne J, Berkhout M, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol. 2001;117(2):294-300.
31. Pasquali E, García-Borrón JC, Fargnoli MC, et al; M-SKIP Study Group. MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: A pooled-Analysis from the M-SKIP project. Int J Cancer. 2015;136(3): 618-631.
32. Nasti TH, Timares L. MC1R, eumelanin and pheomelanin: Their role in determining the susceptibility to skin cancer. Photochem Photobiol. 2015;91(1):188-200.
33. Delaney A, Keighren M, Fleetwood-Walker SM, Jackson IJ. Involvement of the melanocortin-1 receptor in acute pain and pain of inflammatory but not neuropathic origin. PLoS One. 2010;5(9):e12498.
34. Gefeller O. Invited commentary: recall bias in melanoma-much ado about almost nothing? Am J Epidemiol. 2009;169(3):267-270.
35. Parr CL, Hjartaker A, Laake P, Lund E, Veierød MB. Recall bias in melanoma risk factors and measurement error effects: A nested case-control study within the NorwegianWomen and Cancer Study. Am J Epidemiol. 2009;169(3):257-266.
36. Davies JR, Randerson-Moor J, Kukalizch K, et al. Inherited variants in the MC1R gene and survival from cutaneous melanoma: A BioGenoMEL study. Pigment Cell Melanoma Res. 2012;25(3):384-394.
37. Taylor NJ, Reiner AS, Begg CB, et al; GEM Study Group. Inherited variation at MC1R and ASIP and association with melanoma-specific survival. Int J Cancer. 2015;136(11):2659-2667.
38. Cust AE, Goumas C, Vuong K, et al. MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: An Australian case-control-family study. BMC Cancer. 2013;13:406.